Viewing Study NCT04653883



Ignite Creation Date: 2024-05-06 @ 3:30 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04653883
Status: COMPLETED
Last Update Posted: 2020-12-29
First Post: 2020-09-04

Brief Title: Prognostic Impact of Sleep Disorders in Patients Pro-TSIC Study
Sponsor: University Hospital Montpellier
Organization: University Hospital Montpellier

Study Overview

Official Title: Prognostic Impact of Sleep Disorders in Patients With Heart
Status: COMPLETED
Status Verified Date: 2020-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Pro-TSIC
Brief Summary: Heart failure HF is a common and progressive condition associated with significant morbidity and mortality Only 25-35 of patients survive 5 years after diagnosisSleep disorders are frequently found in this population with up to 94 of patients complaining of sleep disorders Of these insomnia and sleep disorders are the most common The frequency of restless legs syndrome RLS varies between 4 and 40 depending on the studies Patients with HF frequently experience poor sleep quality which is associated with deterioration in quality of life alertness and mood

Few studies have examined the prognostic impact of sleep disturbances in this population A greater morbidity and mortality is observed in the event of poor quality sleep or in the presence of sleep breathing disorders

The investigators therefore propose to evaluate the sleep disorders of patients with HF by self-administered questionnaires hypothesizing that complaints of poor sleep are linked to a poorer cardiovascular prognosis
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None